Mirae Asset Global Investments
RLAY icon

Mirae Asset Global Investments’s Relay Therapeutics RLAY Stock Holding History

Mirae Asset Global Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Buy
9,593
+271
+3% +$3.93K ﹤0.01% 1139
2026
Q1 		$92.8K Buy
9,322
+900
+11% +$8.05K ﹤0.01% 1197
2025
Q4 		$71.3K Buy
8,422
+1,757
+26% +$12.5K ﹤0.01% 1326
2025
Q3 		$34.8K Buy
6,665
+42
+0.6% +$160 ﹤0.01% 1402
2025
Q2 		$22.9K Buy
6,623
+1,103
+20% +$3.28K ﹤0.01% 1379
2025
Q1 		$15K Sell
5,520
-58
-1% -$227 ﹤0.01% 1420
2024
Q4 		$24.3K Buy
5,578
+735
+15% +$4K ﹤0.01% 1390
2024
Q3 		$36.1K Buy
4,843
+880
+22% +$6.57K ﹤0.01% 1357
2024
Q2 		$25K Sell
3,963
-50,954
-93% -$348K ﹤0.01% 1353
2024
Q1 		$704K Buy
54,917
+3,684
+7% +$35.9K ﹤0.01% 1727
2023
Q4 		$564K Sell
51,233
-786
-2% -$6.63K ﹤0.01% 1906
2023
Q3 		$437K Sell
52,019
-9,174
-15% -$98.7K ﹤0.01% 1948
2023
Q2 		$774K Buy
61,193
+4,385
+8% +$54.5K ﹤0.01% 1723
2023
Q1 		$936K Buy
56,808
+16,747
+42% +$300K ﹤0.01% 1580
2022
Q4 		$599K Buy
40,061
+5,271
+15% +$101K ﹤0.01% 1789
2022
Q3 		$778K Buy
34,790
+11,051
+47% +$242K ﹤0.01% 1620
2022
Q2 		$397K Buy
+23,739
New +$509K ﹤0.01% 1857

Other funds holding RLAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Mirae Asset Global Investments's RLAY Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Relay Therapeutics (RLAY) stake by 2.9% in Q2 2026, buying an estimated $3.93K and bringing the position to 9,593 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Mirae Asset Global Investments first reported a position in RLAY in Q2 2022 and has held it in 17 quarters since. The position peaked at $936K in Q1 2023. 75 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Mirae Asset Global Investments held 9,593 shares of Relay Therapeutics worth $179K as of Q2 2026.
  • Mirae Asset Global Investments bought 271 Relay Therapeutics shares in Q2 2026, an estimated $3.93K.
  • Relay Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1139 holding.
  • Mirae Asset Global Investments first reported a position in Relay Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Relay Therapeutics position peaked at $936K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.